Forte Biosciences, Inc. (FBRX)

Forte Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	106.14	22.24	37.13	41.1	42.04	58.77
Short-Term Investments	-	36.12	-	-	-	-
Cash & Short-Term Investments	106.14	58.37	37.13	41.1	42.04	58.77
Cash Growth	333.28%	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Prepaid Expenses	0.88	2.65	1.04	0.34	0.39	0.96
Other Current Assets	0.59	0.34	0.17	0.07	0.09	0.18
Total Current Assets	107.62	61.35	38.33	41.51	42.52	59.9
Property, Plant & Equipment	0.11	0.08	0.11	-	-	0.1
Long-Term Deferred Charges	-	-	-	-	0.11	0.29
Other Long-Term Assets	0.06	0.14	0.54	0.49	0.68	0.96
Total Assets	107.78	61.56	38.98	42	43.31	61.24
Accounts Payable	5.3	4.88	1.42	1.15	0.95	1.24
Accrued Expenses	3.87	4.2	2.24	2.03	0.81	1.02
Total Current Liabilities	9.17	9.08	3.67	3.18	1.76	2.26
Total Liabilities	9.17	9.08	3.67	3.18	1.76	2.26
Common Stock	0.01	0.01	0	0.02	0.02	0.01
Additional Paid-In Capital	279.5	206.46	153.83	125.84	114.7	110.42
Retained Earnings	-180.9	-154	-118.52	-87.04	-73.17	-51.46
Comprehensive Income & Other	-	0.01	0	-	-	-
Total Common Equity	98.61	52.48	35.31	38.82	41.55	58.98
Shareholders' Equity	98.61	52.48	35.31	38.82	41.55	58.98
Total Liabilities & Equity	107.78	61.56	38.98	42	43.31	61.24
Net Cash (Debt)	106.14	58.37	37.13	41.1	42.04	58.77
Net Cash Growth	333.28%	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Net Cash Per Share	13.64	20.02	29.40	59.11	75.25	199.64
Filing Date Shares Outstanding	12.43	6.58	1.46	0.84	0.59	0.54
Total Common Shares Outstanding	12.28	6.39	1.45	0.84	0.59	0.51
Working Capital	98.45	52.27	34.66	38.33	40.76	57.64
Book Value Per Share	8.03	8.21	24.30	46.21	70.40	114.92
Tangible Book Value	98.61	52.48	35.31	38.82	41.55	58.98
Tangible Book Value Per Share	8.03	8.21	24.30	46.21	70.40	114.92
Machinery	0.19	0.13	0.12	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q